T. Standl et al., ACUTE HEMODYNAMIC-EFFECTS OF PREOPERATIVE HEMODILUTION WITH BOVINE HEMOGLOBIN FOR LIVER SURGERY, Anasthesist, 46(9), 1997, pp. 763-770
Haemoglobin solutions can be an alternative to allogeneic red-cell tra
nsfusions because they combine colloid osmotic with oxygen transport p
roperties. Since severe toxic side effects have been overcome by ultra
purification, clinical interest has been focused on haemodynamics chan
ges during application of haemoglobin preparations. The present clinic
al study examines changes of haemodynamic and oxygen transport paramet
ers during and after haemodilution with ultrapurified polymerized bovi
ne haemoglobin (HBOC-201) in comparison to hydroxyethyl starch (HES).
Methods: After approval of the Ethics Committee, 12 patients (6 males
and 6 females, mean age 59 +/- 10 years, ASA 1-2) undergoing elective
liver resection were randomly allocated to receive either 3 ml.kg(-1)
6% HES 70000/0.5 (group 1) or 0.49.kg(-1) HBOC-201 (group 2) within 30
min following autologous blood donation of 1 I and substitution with
2 I Ringer's lactate. Measurements of blood gases, haemodynamics, and
oxygen transport parameters were performed after induction of general
anaesthesia, prior to and after blood donation, during and after infus
ion,at the beginning of surgery, and in the intensive care unit.Result
s: Demographic characteristics did not differ between groups. In contr
ast to the HES group, mean arterial pressure increased by 18% over bas
eline measurements in group 2. While pulmonary vascular resistance sho
wed a trend to higher values in group 2, systemic vascular resistance
increased to a maximum of 42% over baseline in group 2 and was twice a
s high as in the HES group. The cardiac index was lower in the HBOC-20
1 group than in the HES group. During and after HBOC-201 infusion, mix
ed-venous oxygen saturation and content and calculated oxygen delivery
were lower in group 2 in comparison to group 1, while the oxygen extr
action ratio was higher in group 2. Free haemoglobin reached a maximal
concentration of 1.0 +/- 0.2 g.dl(-1) 30 min after the HBOC-201 infus
ion was started, but was not detectable in urine over time. The mean i
ntravascular half-life of HBOC-201 was 8.5 h. Conclusions: Patients di
d not show any severe complications during and after infusion of HBOC-
2O1. However, vasoconstrictive side effects resulted in increased syst
emic but not pulmonary resistance. Ongoing studies with higher doses o
f HBOC-201 applied in a larger number of patients will probably reveal
potential clinical consequences of the demonstrated haemodynamic chan
ges.